Isotherapeutics Group

IsoTherapeutics Group, LLC (IsoTherapeutics) is a radiopharmaceutical organization established in 2005 by two enterprising scientists with a keen interest in advancing the technology of radiopharmaceuticals. These scientists, previously employed at the Dow Chemical Company, conceived QUADRAMET®, a radiopharmaceutical designed to address bone pain caused by metastatic cancer, as well as treatments for conditions such as arthritis, osteoporosis, and osteomyelitis, among others. IsoTherapeutics' scientists have been granted more than 100 patents for their work in developing chemistry and radiopharmaceutical formulations.